A Plasmodium-encoded cytokine suppresses T-cell immunity during malaria

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 31, 2012, Pages

  Sun, Tiffany ^a   Holowka, Thomas ^a   Song, Yan ^a   Zierow, Swen ^a   Leng, Lin ^a   Chen, Yibang ^b   Xiong, Huabao ^b   Griffith, Jason ^a   Nouraie, Mehdi ^c   Thuma, Philip E ^d   Lolis, Elias ^a   Janse, Chris J ^e   Gordeuk, Victor R ^c   Augustijn, Kevin ^e   Bucala, Richard ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c HOWARD UNIVERSITY   (United States)

^d Malaria Institute at Macha   (Zambia)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Immune evasion; Vaccine

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; MIGRATION INHIBITION FACTOR; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL MIGRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; MACROPHAGE; MALARIA; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; EVOLUTION, MOLECULAR; HUMANS; IMMUNOLOGIC MEMORY; MALARIA, FALCIPARUM; MICE; MICE, INBRED BALB C; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTOZOAN PROTEINS;

PLASMODIUM BERGHEI;

EID: 84864514340     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1206573109     Document Type: Article

References (64)

1. Langhorne J, Ndungu FM, Sponaas AM, Marsh K (2008) Immunity to malaria: More questions than answers. Nat Immunol 9:725-732. (Pubitemid 351859155)
2. Grun JL, Weidanz WP (1983) Antibody-independent immunity to reinfection malaria in B-cell-deficient mice. Infect Immun 41:1197-1204. (Pubitemid 13048597)
3. Taylor-Robinson AW, Phillips RS, Severn A, Moncada S, Liew FY (1993) The role of TH1 and TH2 cells in a rodent malaria infection. Science 260:1931-1934. (Pubitemid 23258272)
4. Kumar S, Good MF, Dontfraid F, Vinetz JM, Miller LH (1989) Interdependence of CD4+ T cells and malarial spleen in immunity to Plasmodium vinckei vinckei. Relevance to vaccine development. J Immunol 143:2017-2023. (Pubitemid 19241223)
5. Lumsden JM, et al. (2011) Protective immunity induced with the RTS,S/AS vaccine is associated with IL-2 and TNF-α producing effector and central memory CD4 T cells. PLoS ONE 6:e20775.
6. Stephens R, et al. (2005) Malaria-specific transgenic CD4(+) T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance. Blood 106:1676-1684. (Pubitemid 41208581)
7. Pombo DJ, et al. (2002) Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet 360:610-617. (Pubitemid 35232195)
8. Good MF, Xu H, Wykes M, Engwerda CR (2005) Development and regulation of cell-mediated immune responses to the blood stages of malaria: Implications for vaccine research. Annu Rev Immunol 23:69-99. (Pubitemid 40563165)
9. Todryk SM, et al. (2009) Multiple functions of human T cells generated by experimental malaria challenge. Eur J Immunol 39:3042-3051.
10. Taylor JJ, Jenkins MK (2011) CD4+ memory T cell survival. Curr Opin Immunol 23:319-323.
11. Joshi NS, et al. (2007) Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27:281-295. (Pubitemid 47284924)
12. Xu H, et al. (2002) The mechanism and significance of deletion of parasite-specific CD4(+) T cells in malaria infection. J Exp Med 195:881-892. (Pubitemid 34286759)
13. Luty AJ, et al. (1999) Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J Infect Dis 179:980-988. (Pubitemid 29159345)
14. Schofield L, et al. (1987) Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330:664-666. (Pubitemid 18005584)
15. Obar JJ, et al. (2011) Pathogen-induced inflammatory environment controls effector and memory CD8+ T cell differentiation. J Immunol 187:4967-4978.
16. Villegas-Mendez A, et al. (2011) Heterogeneous and tissue-specific regulation of effector T cell responses by IFN-gamma during Plasmodium berghei ANKA infection. J Immunol 187:2885-2897.
17. Bejon P, et al. (2007) The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum. J Immunol 179:4193-4201.
18. de Kossodo S, Grau GE (1993) Profiles of cytokine production in relation with susceptibility to cerebral malaria. J Immunol 151:4811-4820.
19. Macatonia SE, et al. (1995) Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 154:5071-5079.
20. Refaeli Y, Van Parijs L, Alexander SI, Abbas AK (2002) Interferon gamma is required for activation-induced death of T lymphocytes. J Exp Med 196:999-1005.
21. Badovinac VP, Porter BB, Harty JT (2004) CD8+ T cell contraction is controlled by early inflammation. Nat Immunol 5:809-817. (Pubitemid 39172974)
22. Pearce EL, Shen H (2007) Generation of CD8 T cell memory is regulated by IL-12. J Immunol 179:2074-2081.
23. Stevenson MM, Tam MF, Wolf SF, Sher A (1995) IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-γ and TNF-α and occurs via a nitric oxide-dependent mechanism. J Immunol 155:2545-2556.
24. Yoshimoto T, et al. (1998) A pathogenic role of IL-12 in blood-stage murine malaria lethal strain Plasmodium berghei NK65 infection. J Immunol 160:5500-5505. (Pubitemid 28267842)
25. Griffith JW, et al. (2007) Toll-like receptor modulation of murine cerebral malaria is dependent on the genetic background of the host. J Infect Dis 196:1553-1564. (Pubitemid 351411993)
26. Chandele A, Mukerjee P, Das G, Ahmed R, Chauhan VS (2011) Phenotypic and functional profiling of malaria-induced CD8 and CD4 T cells during blood-stage infection with Plasmodium yoelii. Immunology 132:273-286.
27. Szabo SJ, et al. (2002) Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295:338-342. (Pubitemid 34074366)
28. Sullivan BM, Juedes A, Szabo SJ, von Herrath M, Glimcher LH (2003) Antigen-driven effector CD8 T cell function regulated by T-bet. Proc Natl Acad Sci USA 100:15818-15823. (Pubitemid 38021073)
29. Vermeire JJ, Cho Y, Lolis E, Bucala R, Cappello M (2008) Orthologs of macrophage migration inhibitory factor from parasitic nematodes. Trends Parasitol 24:355-363.
30. Calandra T, Bernhagen J, Mitchell RA, Bucala R (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179:1895-1902. (Pubitemid 24155670)
31. Dobson SE, et al. (2009) The crystal structures of macrophage migration inhibitory factor from Plasmodium falciparum and Plasmodium berghei. Protein Sci 18:2578-2591.
32. Molyneux ME, Taylor TE, Wirima JJ, Borgstein A (1989) Clinical features and prognostic indicators in paediatric cerebral malaria: A study of 131 comatose Malawian children. Q J Med 71:441-459. (Pubitemid 19161768)
33. Thuma PE, et al. (2011) Distinct clinical and immunologic profiles in severe malarial anemia and cerebral malaria in Zambia. J Infect Dis 203:211-219.
34. Kwiatkowski D, et al. (1990) TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336:1201-1204. (Pubitemid 20382913)
35. Leng L, et al. (2003) MIF signal transduction initiated by binding to CD74. J Exp Med 197:1467-1476. (Pubitemid 36686708)
36. Augustijn KD, et al. (2007) Functional characterization of the Plasmodium falciparum and P. berghei homologues of macrophage migration inhibitory factor. Infect Immun 75:1116-1128. (Pubitemid 46385802)
37. Cordery DV, et al. (2007) Characterization of a Plasmodium falciparum macrophage-migration inhibitory factor homologue. J Infect Dis 195:905-912. (Pubitemid 46363937)
38. von der Weid T, Honarvar N, Langhorne J (1996) Gene-targeted mice lacking B cells are unable to eliminate a blood stage malaria infection. J Immunol 156:2510-2516. (Pubitemid 26091578)
39. Butler NS, et al. (2012) Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat Immunol 13:188-195.
40. Dalton DK, Haynes L, Chu CQ, Swain SL, Wittmer S (2000) Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J Exp Med 192:117-122. (Pubitemid 30470812)
41. Li J, Huston G, Swain SL (2003) IL-7 promotes the transition of CD4 effectors to persistent memory cells. J Exp Med 198:1807-1815. (Pubitemid 38032114)
42. Schluns KS, Kieper WC, Jameson SC, Lefrançois L (2000) Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo. Nat Immunol 1:426-432.
43. Colpitts SL, Dalton NM, Scott P (2009) IL-7 receptor expression provides the potential for long-term survival of both CD62Lhigh central memory T cells and Th1 effector cells during Leishmania major infection. J Immunol 182:5702-5711.
44. Stephens R, Langhorne J (2010) Effector memory Th1 CD4 T cells are maintained in a mouse model of chronic malaria. PLoS Pathog 6:e1001208.
45. Darrah PA, et al. (2007) Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13:843-850. (Pubitemid 47038186)
46. Marshall HD, et al. (2011) Differential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4(+) cell properties during viral infection. Immunity 35:633-646.
47. Agnello D, et al. (2003) Cytokines and transcription factors that regulate T helper cell differentiation: New players and new insights. J Clin Immunol 23:147-161. (Pubitemid 36522792)
48. Lighvani AA, et al. (2001) T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc Natl Acad Sci USA 98:15137-15142. (Pubitemid 34013982)
49. Wojciechowski S, et al. (2007) Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis. J Exp Med 204:1665-1675. (Pubitemid 47048032)
50. Pierce SK, Miller LH (2009) World Malaria Day 2009: What malaria knows about the immune system that immunologists still do not. J Immunol 182:5171-5177.
51. Good MF, Stanisic D, Xu H, Elliott S, Wykes M (2004) The immunological challenge to developing a vaccine to the blood stages of malaria parasites. Immunol Rev 201:254-267. (Pubitemid 39318457)
52. Sacks D, Sher A (2002) Evasion of innate immunity by parasitic protozoa. Nat Immunol 3:1041-1047. (Pubitemid 35363655)
53. Langhorne J, et al. (2004) Dendritic cells, pro-inflammatory responses, and antigen presentation in a rodent malaria infection. Immunol Rev 201:35-47. (Pubitemid 39318442)
54. Thorat S, Daly TM, Bergman LW, Burns JM, Jr. (2010) Elevated levels of the Plasmodium yoelii homologue of macrophage migration inhibitory factor attenuate blood-stage malaria. Infect Immun 78:5151-5162.
55. Miller JL, Harupa A, Kappe SH, Mikolajczak SA (2012) Plasmodium yoelii macrophage migration inhibitory factor is necessary for efficient liver-stage development. Infect Immun 80:1399-1407.
56. Hedrick PW (2011) Population genetics of malaria resistance in humans. Heredity (Edinb) 107:283-304.
57. Thera MA, Plowe CV (2012) Vaccines for malaria: How close are we? Annu Rev Med 63:345-357.
58. Kamir D, et al. (2008) A Leishmania ortholog of macrophage migration inhibitory factor modulates host macrophage responses. J Immunol 180:8250-8261.
59. Cho Y, et al. (2007) Structural and functional characterization of a secreted hookworm Macrophage Migration Inhibitory Factor (MIF) that interacts with the human MIF receptor CD74. J Biol Chem 282:23447-23456. (Pubitemid 47311922)
60. Merk M, et al. (2011) The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF). Proc Natl Acad Sci USA 108:E577-E585.
61. Scharton-Kersten T, Afonso LC, Wysocka M, Trinchieri G, Scott P (1995) IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J Immunol 154:5320-5330.
62. Kumar KA, Oliveira GA, Edelman R, Nardin E, Nussenzweig V (2004) Quantitative Plasmodium sporozoite neutralization assay (TSNA). J Immunol Methods 292:157-164. (Pubitemid 39179871)
63. Franke-Fayard B, et al. (2004) A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Mol Biochem Parasitol 137:23-33. (Pubitemid 38987939)
64. Shi X, et al. (2006) CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25:595-606. (Pubitemid 44529040)